Genzyme Virotech GmbH Emerges After Consolidation

Strategic Insights -

Genzyme Corp., a leading biotechnology company, has consolidated the name of its German subsidiary, Virotech System-Diagnostika GmbH, creating Genzyme Virotech GmbH. This change is effective immediately. The combined entity aims to leverage complementary strengths and expand its presence in Germany and Europe. Peter Kessler, managing director of Genzyme Virotech, emphasized the strategic opportunity presented by the acquisition and the company's growth prospects in the German diagnostics market.

Key Takeaways:

  • The consolidation of Virotech System-Diagnostika GmbH and Genzyme Corp. has resulted in the formation of Genzyme Virotech GmbH, effective immediately.
  • Genzyme Virotech GmbH has established itself as a market leader in Germany, with a strong presence in the development, manufacturing, and marketing of diagnostic test kits for infectious diseases.
  • The company specializes in test kits for diagnosing infectious diseases, with a focus on the German market and its export business.
  • Genzyme Diagnostics, the diagnostic products division of Genzyme, has created an entity with enhanced leadership position in the German diagnostics market through the acquisition.
  • Genzyme Virotech GmbH has positioned itself to expand its export business in the coming years, leveraging the complementary strengths of Virotech and Genzyme.
  • The company has a significant presence in Germany, with a location in Ruesselsheim.

Statistics:

  • Genzyme Virotech GmbH was founded in 1986, with its name change effective January 10, 1995.
  • The company has established itself as a market leader in Germany, with a strong presence in the diagnostic test kit market.
  • Genzyme Corp. is one of the world's top five biotechnology companies in terms of sales.
  • Genzyme Virotech GmbH has created an entitiy with an enhanced leadership position in the German diagnostics market.

Sources:

  • Business Wire, "Virotech System-Diagnostika GmbH Changes Its Name to Genzyme Virotech GmbH," January 10, 1995
  • Original company release.